AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35585937 — intervention group
Group type: COMPARATOR
Intervention: Muscle Energy Technique (MET)
Number of subjects: 100
Study 35585937 — intervention group
Group type: COMPARATOR
Intervention: Neurac method
Number of subjects: 100
Study 33754604 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracorporeal injection (ICI)
Number of subjects: 160
Study 33754604 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracorporeal injection (ICI) + phosphodiesterase inhibitor (PDE5i)
Number of subjects: 160
Study 33754604 — intervention group
Group type: COMPARATOR
Intervention: Phosphodiesterase inhibitor (PDE5i)
Number of subjects: 160
Study 34658304 — intervention group
Group type: EXPERIMENTAL
Intervention: Designated-Video Group (DVG)
Number of subjects: 22
Study 34658304 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-Searching Group (FSG)
Number of subjects: 22
Study 34658304 — intervention group
Group type: COMPARATOR
Intervention: Textbook Group (TG)
Number of subjects: 22
Study 33766151 — intervention group
Group type: EXPERIMENTAL
Intervention: Active ABMT
Number of subjects: 145
Study 33766151 — intervention group
Group type: COMPARATOR
Intervention: Sham ABMT
Number of subjects: 145
Study 33766151 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only
Number of subjects: 145
Study 32091672 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 28
Study 32091672 — intervention group
Group type: COMPARATOR
Intervention: Sham RIPC (control)
Number of subjects: 28
Study 35220651 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum CYFRA21‐1 levels
Number of subjects: 824
Study 35220651 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of MELD and CYFRA21‐1
Number of subjects: 824
Study 35220651 — intervention group
Group type: EXPERIMENTAL
Intervention: CYFRA21‐1
Number of subjects: 824
Study 32243651 — intervention group
Group type: COMPARATOR
Intervention: Ham F12 medium (Group A)
Number of subjects: 18
Study 32243651 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ng/mL recombinant basic fibroblast growth factor (bFGF) and 25 mg/500 mL 3′5′ cyclic adenosine monophosphate (cAMP) (Group B)
Number of subjects: 18
Study 34861764 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of stuttering + low communication competence
Number of subjects: 158
Study 34861764 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of stuttering + low communication competence
Number of subjects: 158
Study 34861764 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of stuttering + high communication competence
Number of subjects: 158
Study 34861764 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of stuttering + high communication competence
Number of subjects: 158
Study 34861764 — intervention group
Group type: EXPERIMENTAL
Intervention: High communication competence
Number of subjects: 158
Study 34861764 — intervention group
Group type: EXPERIMENTAL
Intervention: Low communication competence
Number of subjects: 158
Study 33285699 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) enhancement during arthroscopic rotator cuff repair
Number of subjects: 0
Study 33285699 — intervention group
Group type: COMPARATOR
Intervention: Standard arthroscopic rotator cuff repair without PRP
Number of subjects: 0
Study 35130374 — intervention group
Group type: EXPERIMENTAL
Intervention: M1 + S1 - tDCS (active stimulation for 20 min)
Number of subjects: 39
Study 35130374 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (control stimulation for 20 min)
Number of subjects: 39
Study 33248361 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical activity (PA) through combined PA counselling and pedometer-based feedback
Number of subjects: 54
Study 33248361 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 54
Study 35998706 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal telemonitoring
Number of subjects: 168
Study 35998706 — intervention group
Group type: COMPARATOR
Intervention: Usual CPAP telemonitoring
Number of subjects: 168
Study 32829594 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position group
Number of subjects: 120
Study 32829594 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral position group
Number of subjects: 120
Study 32829594 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid position group
Number of subjects: 120
Study 32621663 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical triamcinolone acetonide 0.1% ointment twice daily for 2 weeks
Number of subjects: 50
Study 32621663 — intervention group
Group type: COMPARATOR
Intervention: Topical tacrolimus 0.03% ointment twice daily for 2 weeks
Number of subjects: 50
Study 34988847 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontiguous (D-PVI) radiofrequency lesions
Number of subjects: 36
Study 34988847 — intervention group
Group type: COMPARATOR
Intervention: Contiguous (C-PVI) radiofrequency lesions
Number of subjects: 36
Study 33896627 — intervention group
Group type: COMPARATOR
Intervention: Canola meal (CM) inclusion at 0% crude protein from CM (CM0)
Number of subjects: 50
Study 33896627 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola meal (CM) inclusion at 15% crude protein from CM (CM15)
Number of subjects: 50
Study 33896627 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola meal (CM) inclusion at 30% crude protein from CM (CM30)
Number of subjects: 50
Study 33896627 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola meal (CM) inclusion at 45% crude protein from CM (CM45)
Number of subjects: 50
Study 33896627 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola meal (CM) inclusion at 60% crude protein from CM (CM60)
Number of subjects: 50
Study 36128952 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based interventions for obesity
Number of subjects: 25
Study 34941914 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigerase®
Number of subjects: 46
Study 34941914 — intervention group
Group type: COMPARATOR
Intervention: Pulmozyme®
Number of subjects: 46
Study 36184966 — intervention group
Group type: EXPERIMENTAL
Intervention: Park prescription (Park Rx) during routine clinical visits
Number of subjects: 500
Study 36184966 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control arm)
Number of subjects: 500
Study 33523583 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver–oncologist prognostic concordance
Number of subjects: 411
Study 33523583 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver–oncologist prognostic concordance among caregivers with low mastery
Number of subjects: 411
Study 33523583 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver mastery
Number of subjects: 411
Study 33523583 — intervention group
Group type: COMPARATOR
Intervention: Caregiver distress and quality of life (QoL) measures
Number of subjects: 411
Study 36106673 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Skill Training (MST)
Number of subjects: 83
Study 36106673 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength and Flexibility Exercise (SFE)
Number of subjects: 83
Study 36106673 — intervention group
Group type: COMPARATOR
Intervention: Disability
Number of subjects: 83
Study 33533285 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic quadriceps muscle strength assessed with one-repetition maximum (1RM)
Number of subjects: 89
Study 33533285 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric quadriceps muscle strength assessed with hand-held dynamometry (HHD)
Number of subjects: 89
Study 32491082 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based training to promote breast cancer screening (low worry intervention group)
Number of subjects: 285
Study 32491082 — intervention group
Group type: COMPARATOR
Intervention: Theory-based training to promote breast cancer screening (high worry control group)
Number of subjects: 285
Study 32491082 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based training to promote breast cancer screening (low worry intervention and high worry intervention)
Number of subjects: 285
Study 34922649 — intervention group
Group type: EXPERIMENTAL
Intervention: Namilumab (150 mg, single intravenous dose)
Number of subjects: 146
Study 34922649 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg, single intravenous dose)
Number of subjects: 146
Study 34922649 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 146
Study 34922649 — intervention group
Group type: EXPERIMENTAL
Intervention: Namilumab
Number of subjects: 146
Study 34922649 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 146
Study 34507235 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic cartilage with perichondrium composite graft underlay technique
Number of subjects: 80
Study 34507235 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic perichondrial graft overlay and cartilage underlay technique
Number of subjects: 80
Study 32881710 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY) for 30 min, 6 days/week for 8 weeks
Number of subjects: 52
Study 32881710 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY)
Number of subjects: 52
Study 32881710 — intervention group
Group type: COMPARATOR
Intervention: Sitting activity and Suryanamaskar for 4 weeks each (Control)
Number of subjects: 52
Study 36370460 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble CPAP (5-8 cm H2O)
Number of subjects: 7
Study 36370460 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble NIPPV (Phigh 8-10 cm H2O/Plow 5-8 cm H2O)
Number of subjects: 7
Study 32333540 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 104
Study 32333540 — intervention group
Group type: COMPARATOR
Intervention: Sham‐EA
Number of subjects: 104
Study 32333540 — intervention group
Group type: COMPARATOR
Intervention: Epidural block
Number of subjects: 104
Study 36066478 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel training and defecation posture intervention
Number of subjects: 30
Study 36066478 — intervention group
Group type: COMPARATOR
Intervention: General care (control group)
Number of subjects: 30
Study 35512824 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent patella dislocation patients
Number of subjects: 148
Study 33017169 — intervention group
Group type: EXPERIMENTAL
Intervention: HTT technique
Number of subjects: 30
Study 33017169 — intervention group
Group type: EXPERIMENTAL
Intervention: AM portal technique
Number of subjects: 30
Study 33017169 — intervention group
Group type: COMPARATOR
Intervention: TT technique
Number of subjects: 30
Study 34780602 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative mobilization (defined as the fraction of monitored time spent sitting or standing)
Number of subjects: 673
Study 34780602 — intervention group
Group type: EXPERIMENTAL
Intervention: Average pain score increase
Number of subjects: 673
Study 34780602 — intervention group
Group type: COMPARATOR
Intervention: Postoperative complications
Number of subjects: 673
Study 33473174 — intervention group
Group type: EXPERIMENTAL
Intervention: DXA measured VAT mass
Number of subjects: 1482
Study 33473174 — intervention group
Group type: EXPERIMENTAL
Intervention: VAT mass cut-offs
Number of subjects: 1482
Study 33473174 — intervention group
Group type: EXPERIMENTAL
Intervention: DXA measured VAT
Number of subjects: 1482
Study 32491124 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry bed bath
Number of subjects: 15
Study 32491124 — intervention group
Group type: COMPARATOR
Intervention: Traditional bed bath
Number of subjects: 15
Study 35274093 — intervention group
Group type: EXPERIMENTAL
Intervention: CHARM2 intervention (five provider-delivered sessions on gender equity and family planning)
Number of subjects: 1201
Study 35274093 — intervention group
Group type: EXPERIMENTAL
Intervention: CHARM2 intervention
Number of subjects: 1201
Study 35274093 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1201
Study 32558214 — intervention group
Group type: EXPERIMENTAL
Intervention: Home treatment (HoT) after 4–8 weeks of inpatient treatment, with visits by a multi-professional team 3-4 times per week for the first two months and 1-2 times per week for the third and fourth months.
Number of subjects: 22
Study 32683645 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 months of dual antiplatelet therapy (DAPT)
Number of subjects: 1399
Study 32683645 — intervention group
Group type: COMPARATOR
Intervention: 30 months of dual antiplatelet therapy (DAPT)
Number of subjects: 1399
Study 34664829 — intervention group
Group type: EXPERIMENTAL
Intervention: CT nano-contrast agent
Number of subjects: 100
Study 34664829 — intervention group
Group type: COMPARATOR
Intervention: Traditional iohexol contrast agent
Number of subjects: 100
Study 34048083 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training (HIT) for 20 weeks
Number of subjects: 39
Study 34048083 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 39
Study 34048083 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training (HIT)
Number of subjects: 39
Study 34048083 — intervention group
Group type: COMPARATOR
Intervention: High-intensity training (HIT) and Standard care (control)
Number of subjects: 39
Study 36206441 — intervention group
Group type: EXPERIMENTAL
Intervention: Variational entanglement-assisted quantum process tomography with arbitrary ancillary qubits.
Number of subjects: 8
Study 36206441 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicon photonic chip implementation of the method.
Number of subjects: 8
Study 34679211 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month lifestyle intervention using a mobile app and a wearable device
Number of subjects: 173
Study 34679211 — intervention group
Group type: EXPERIMENTAL
Intervention: Average TST of 4.0-5.3 hours
Number of subjects: 173
Study 32333159 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred music exposure
Number of subjects: 60
Study 32333159 — intervention group
Group type: COMPARATOR
Intervention: Active noise-cancelling headphones
Number of subjects: 60
Study 35940001 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisis Line Facilitation (CLF) intervention
Number of subjects: 307
Study 35940001 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 307
Study 34936270 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with wheat-grain moxibustion
Number of subjects: 60
Study 34936270 — intervention group
Group type: COMPARATOR
Intervention: Oral sertraline hydrochloride dispersible tablets, 50 mg once a day
Number of subjects: 60
Study 35943472 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting plus medical therapy (n=176)
Number of subjects: 380
Study 35943472 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone (n=182)
Number of subjects: 380
Study 35943472 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting plus medical therapy (n=171)
Number of subjects: 380
Study 35943472 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone (n=178)
Number of subjects: 380
Study 35943472 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting plus medical therapy (n=168)
Number of subjects: 380
Study 35943472 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone (n=170)
Number of subjects: 380
Study 35943472 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting plus medical therapy (n=160)
Number of subjects: 380
Study 35943472 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone (n=159)
Number of subjects: 380
Study 34341340 — intervention group
Group type: EXPERIMENTAL
Intervention: Variations in headline and image 'package' used in A/B tests.
Number of subjects: 538272878
Study 34341340 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract).
Number of subjects: 538272878
Study 35434041 — intervention group
Group type: EXPERIMENTAL
Intervention: L. plantarum Lp3a; 2×1.0×10^10 CFU for 7 days
Number of subjects: 120
Study 35434041 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 120
Study 32241625 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality meditation for 30 minutes using a head‐mounted display on the evening of the admission day
Number of subjects: 48
Study 32241625 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 48
Study 32241625 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality meditation
Number of subjects: 48
Study 616774454 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 80
Study 616774454 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 80
Study 616774454 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 35810275 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal regurgitation scenario
Number of subjects: 54
Study 35810275 — intervention group
Group type: COMPARATOR
Intervention: Clean airway scenario
Number of subjects: 54
Study 32994531 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium cut-off (MCO) dialyzer
Number of subjects: 49
Study 32994531 — intervention group
Group type: COMPARATOR
Intervention: High-flux group
Number of subjects: 49
Study 35198149 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D daily
Number of subjects: 84
Study 35198149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 34497646 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100000 epinephrine
Number of subjects: 102
Study 34497646 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine with 1:80000 epinephrine
Number of subjects: 102
Study 33901574 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacogenetic optimization arm (varenicline for fast metabolizers, nicotine patch for slow metabolizers)
Number of subjects: 488
Study 33901574 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence counseling arm (Managed Problem Solving - MAPS)
Number of subjects: 488
Study 33901574 — intervention group
Group type: COMPARATOR
Intervention: Control group (varenicline)
Number of subjects: 488
Study 33901574 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard counseling)
Number of subjects: 488
Study 32538028 — intervention group
Group type: EXPERIMENTAL
Intervention: Population size estimation of PWID
Number of subjects: 250
Study 34296374 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivotal response treatment (PRT), conducted three times a week for 2 months, totaling 24 one-hour sessions
Number of subjects: 0
Study 34296374 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 33927229 — intervention group
Group type: EXPERIMENTAL
Intervention: HemoCue
Number of subjects: 0
Study 33927229 — intervention group
Group type: COMPARATOR
Intervention: DBS
Number of subjects: 0
Study 33305625 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation with lavender oil scents
Number of subjects: 40
Study 33305625 — intervention group
Group type: COMPARATOR
Intervention: Vestibular rehabilitation without lavender oil scents
Number of subjects: 40
Study 33757620 — intervention group
Group type: EXPERIMENTAL
Intervention: Building Healthy Children (BHC) intervention
Number of subjects: 0
Study 33757620 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Community Standard
Number of subjects: 0
Study 33402625 — intervention group
Group type: EXPERIMENTAL
Intervention: Magic trick distraction technique
Number of subjects: 60
Study 33402625 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile dental game distraction technique
Number of subjects: 60
Study 33402625 — intervention group
Group type: COMPARATOR
Intervention: TSD (tell-show-do) technique
Number of subjects: 60
Study 35915567 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (5 x 7 cm2, 2 mA, 20 min, anode/cathode over the F4/Fp1)
Number of subjects: 60
Study 35915567 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 60
Study 35915567 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 60
Study 33649113 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir
Number of subjects: 0
Study 33649113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35500453 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day high-fat diet (500 mL of cream, 1700 kcal)
Number of subjects: 9
Study 35500453 — intervention group
Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 9
Study 34336612 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 30
Study 34336612 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia
Number of subjects: 30
Study 34313687 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital and postdischarge quality improvement intervention
Number of subjects: 5647
Study 34313687 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5647
Study 32532313 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp-delivered education programme (health promotion pamphlet and education materials)
Number of subjects: 0
Study 32532313 — intervention group
Group type: COMPARATOR
Intervention: Health promotion pamphlet (control group)
Number of subjects: 0
Study 36278776 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan
Number of subjects: 70
Study 36278776 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 70
Study 34666728 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg every night at bedtime
Number of subjects: 73
Study 34666728 — intervention group
Group type: COMPARATOR
Intervention: Pumpkin seed oil 360 mg twice a day
Number of subjects: 73
Study 34252115 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (CS)
Number of subjects: 117405
Study 34252115 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (CS) short-term use (<365 days)
Number of subjects: 117405
Study 34252115 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (CS) long-term use (>364 days)
Number of subjects: 117405
Study 34252115 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (CS) use in men
Number of subjects: 117405
Study 34252115 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (CS) use in women
Number of subjects: 117405
Study 34252115 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (CS) use in individuals over 70 years
Number of subjects: 117405